Image

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Research Study on Neoadjuvant Treatment for Resectable Pancreatic Cancer

Recruiting
18 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates pancreatic cancer that is resectable or borderline resectable. The purpose of this study is to evaluate the effects of an investigational medication combination given before surgery.

The study evaluates the safety and effectiveness of the investigational medication combination. It focuses on the potential impact on tumor response and immune system involvement in the treatment of pancreatic cancer.

  • Who can participate: Adults over 18 years with confirmed resectable or borderline resectable pancreatic ductal adenocarcinoma can participate. They must have an ECOG performance status of 0-1 and meet specific health criteria.
  • Study details: Participants will receive an investigational medication combination before surgery. Some may receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine.
  • Study timelines and visits: The study will last 16 weeks. The study requires 8 visits.
Print
Study details
    Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Resectable Pancreatic Adenocarcinoma
    Stage I Pancreatic Cancer AJCC v8
    Stage II Pancreatic Cancer AJCC v8
    Stage III Pancreatic Cancer AJCC v8

NCT06423326

Emory University

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.